Dr Ali Vaziri, MD | |
11375 Cortez Blvd, Brooksville, FL 34613-5409 | |
(352) 597-6137 | |
Not Available |
Full Name | Dr Ali Vaziri |
---|---|
Gender | Male |
Speciality | Internal Medicine |
Experience | 11 Years |
Location | 11375 Cortez Blvd, Brooksville, Florida |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1215994942 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208M00000X | Hospitalist | ME131174 (Florida) | Secondary |
207R00000X | Internal Medicine | ME131174 (Florida) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Oak Hill Hospital | Brooksville, FL | Hospital |
Blake Medical Center | Bradenton, FL | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Hospital Medicine Services Of Fl, Llc | 9234596743 | 402 |
News Archive
Advaxis, Inc., a leader in developing the next generation of immunotherapies for cancer and infectious diseases, announced the publication of preclinical research with ADXS-PSA (ADXS31-142), Advaxis' Lm-LLO immunotherapy targeting the PSA antigen associated with prostate cancer.
In advance of a United Nations conference today on the global challenges of treating cancer and other diseases, the UBC Graduate School of Journalism has launched an ambitious multimedia site, The Pain Project, which documents one of the greatest challenges to treating chronic illnesses: severely constrained access to morphine.
Overweight adolescents were twice as likely as their normal weight peers to later develop esophageal cancer in a recent study from Israel. The study, which is published early online in CANCER, a peer-reviewed journal of the American Cancer Society, also found that lower socioeconomic status as well as immigration from higher risk countries were important determinants of gastric cancer.
GenVec, Inc. announced that research regarding GenVec's efforts to create novel vectors for vaccines is appearing in Vol. 28, issue 35, pages 5691-5702 of Vaccine. The article, "Potent immune responses and in vitro pro-inflammatory cytokine suppression by a novel adenovirus vector based on rare human serotype 28," describes GenVec's efforts to identify and utilize novel adenovirus serotypes as vectors in vaccine development.
› Verified 6 days ago
Entity Name | H Lee Moffitt Cancer Ctr & Res Inst Life Time Cancer Scrn Ctr Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1306833595 PECOS PAC ID: 2264337021 Enrollment ID: O20031204000575 |
News Archive
Advaxis, Inc., a leader in developing the next generation of immunotherapies for cancer and infectious diseases, announced the publication of preclinical research with ADXS-PSA (ADXS31-142), Advaxis' Lm-LLO immunotherapy targeting the PSA antigen associated with prostate cancer.
In advance of a United Nations conference today on the global challenges of treating cancer and other diseases, the UBC Graduate School of Journalism has launched an ambitious multimedia site, The Pain Project, which documents one of the greatest challenges to treating chronic illnesses: severely constrained access to morphine.
Overweight adolescents were twice as likely as their normal weight peers to later develop esophageal cancer in a recent study from Israel. The study, which is published early online in CANCER, a peer-reviewed journal of the American Cancer Society, also found that lower socioeconomic status as well as immigration from higher risk countries were important determinants of gastric cancer.
GenVec, Inc. announced that research regarding GenVec's efforts to create novel vectors for vaccines is appearing in Vol. 28, issue 35, pages 5691-5702 of Vaccine. The article, "Potent immune responses and in vitro pro-inflammatory cytokine suppression by a novel adenovirus vector based on rare human serotype 28," describes GenVec's efforts to identify and utilize novel adenovirus serotypes as vectors in vaccine development.
› Verified 6 days ago
Entity Name | Hospital Medicine Services Of Fl, Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1710684857 PECOS PAC ID: 9234596743 Enrollment ID: O20230526001457 |
News Archive
Advaxis, Inc., a leader in developing the next generation of immunotherapies for cancer and infectious diseases, announced the publication of preclinical research with ADXS-PSA (ADXS31-142), Advaxis' Lm-LLO immunotherapy targeting the PSA antigen associated with prostate cancer.
In advance of a United Nations conference today on the global challenges of treating cancer and other diseases, the UBC Graduate School of Journalism has launched an ambitious multimedia site, The Pain Project, which documents one of the greatest challenges to treating chronic illnesses: severely constrained access to morphine.
Overweight adolescents were twice as likely as their normal weight peers to later develop esophageal cancer in a recent study from Israel. The study, which is published early online in CANCER, a peer-reviewed journal of the American Cancer Society, also found that lower socioeconomic status as well as immigration from higher risk countries were important determinants of gastric cancer.
GenVec, Inc. announced that research regarding GenVec's efforts to create novel vectors for vaccines is appearing in Vol. 28, issue 35, pages 5691-5702 of Vaccine. The article, "Potent immune responses and in vitro pro-inflammatory cytokine suppression by a novel adenovirus vector based on rare human serotype 28," describes GenVec's efforts to identify and utilize novel adenovirus serotypes as vectors in vaccine development.
› Verified 6 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Ali Vaziri, MD 11375 Cortez Blvd, Brooksville, FL 34613-5409 Ph: (352) 597-6137 | Dr Ali Vaziri, MD 11375 Cortez Blvd, Brooksville, FL 34613-5409 Ph: (352) 597-6137 |
News Archive
Advaxis, Inc., a leader in developing the next generation of immunotherapies for cancer and infectious diseases, announced the publication of preclinical research with ADXS-PSA (ADXS31-142), Advaxis' Lm-LLO immunotherapy targeting the PSA antigen associated with prostate cancer.
In advance of a United Nations conference today on the global challenges of treating cancer and other diseases, the UBC Graduate School of Journalism has launched an ambitious multimedia site, The Pain Project, which documents one of the greatest challenges to treating chronic illnesses: severely constrained access to morphine.
Overweight adolescents were twice as likely as their normal weight peers to later develop esophageal cancer in a recent study from Israel. The study, which is published early online in CANCER, a peer-reviewed journal of the American Cancer Society, also found that lower socioeconomic status as well as immigration from higher risk countries were important determinants of gastric cancer.
GenVec, Inc. announced that research regarding GenVec's efforts to create novel vectors for vaccines is appearing in Vol. 28, issue 35, pages 5691-5702 of Vaccine. The article, "Potent immune responses and in vitro pro-inflammatory cytokine suppression by a novel adenovirus vector based on rare human serotype 28," describes GenVec's efforts to identify and utilize novel adenovirus serotypes as vectors in vaccine development.
› Verified 6 days ago
Mildred Veronica Farmer, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 16176 Cortez Blvd, Brooksville, FL 34601 Phone: 352-597-8839 | |
Dr. Syed Wajahat Ali, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 11451 Cortez Blvd, Brooksville, FL 34613 Phone: 352-797-9677 Fax: 352-600-8913 | |
Dr. Raju V Rao, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 14529 Cortez Blvd, Florida Cancer Specialists P L, Brooksville, FL 34613 Phone: 352-596-1401 Fax: 352-597-2337 | |
Mowaffak Atfeh, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 11373 Cortez Blvd, Suite 307, Brooksville, FL 34613 Phone: 352-596-1616 Fax: 352-596-5707 | |
Eric Sladek, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 11375 Cortez Blvd, Brooksville, FL 34613 Phone: 352-597-6137 | |
Dr. Sheldon M. Hoxie, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 14540 Cortez Blvd, Brooksville, FL 34613 Phone: 352-597-8287 | |
Ravishankar L Rao, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 15435 Cortez Blvd, Brooksville, FL 34613 Phone: 352-796-2909 Fax: 352-796-8196 |